Skip to main content
All lobbying filings

PHILIPS HOLDING USA, INC.

Lobbying for PHILIPS HOLDING USA INC.

 Filing 1st Quarter - Amendment
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $580,000.00 expenses · posted Apr 23, 2026

Official filing document

 Bills named in this filing 8
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
  • S 2983
    Extending Expired Cybersecurity Authorities Act
  • S 1399
    Health Tech Investment Act
  • HR 6197
    Health Tech Investment Act
  • HR 5081
    Telehealth Modernization Act
  • S 2709
    Telehealth Modernization Act
  • S 1717
    Ensuring Patient Access to Critical Breakthrough Products Act of 2025
  • HR 5343
    Ensuring Patient Access to Critical Breakthrough Products Act
 Lobbying activity 9
Veterans

U.S. Department of Veteran Affairs' acquisition process Telehealth for veterans Tele-critical care for Dept of Defense Nationwide expansion of tele-critical care program Digital Pathology RATE (Rapid Analysis of Threat Exposure)

Defense

FY2027 National Defense Authorization Act - Right to repair provisions Telehealth in DOD

Chemicals/Chemical Industry

EPA ethylene oxide (EtO) regulations under FIFRA and NESHAP review - device sterilization

Tariff (miscellaneous tariff bills)

Tariff policy and the impact on patient access to medical devices Changes in U.S. Customs duties on imports, including negotiations on reciprocal tariffs with the EU and China.

Taxation/Internal Revenue Code

Changes in international tax provisions in H.R. 1, including section 899 and related BEAT provisions.

Homeland Security

S. 2983, Protecting America from Cyberthreats Act, all provisions

Medicare/Medicaid

S. 1399, the Health Tech Investment Act (whole bill) and H.R. 6197, the Health Tech Investment Act (whole bill) Site neutrality payments under Medicare Medicare Physician Fee Schedule reform Extension of Medicare telehealth waivers - H.R. 5081/S. 2709 - The Telehealth Modernization Act (all sections) S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act (whole bill) and H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act (whole bill) H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act - whole bill

Health Issues

Third-party servicing of medical devices, right-to-repair of medical devices, remanufacturing of medical devices Cybersecurity of medical devices FDA regulation of Artificial Intelligence EPA ethylene oxide (EtO) regulations under FIFRA and NESHAP review - device sterilization Efforts to improve access to healthcare for underserved communities and activities to enhance maternal healthcare Sustainability in healthcare throughout the value chain including procurement, product development and design, and the benefits thereof

Budget/Appropriations

FY 2027 Veterans Affairs Appropriations, in general with some focus on telehealth provisions FY 2027 Defense Department Appropriations National Defense Authorization Act for Fiscal Year 2027, including issues related to RATE and low helium MRIs

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem